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Abstract
Oral cancer accounts for over 30% of all cancers in India. Early detection 
followed by appropriate treatment, can increase cure rates to 80 or 90%, and greatly 
improve  the  quality  of  life  by  minimizing  extensive,  debilitating  treatments  . 
Circulatory epithelial tumour markers were previously investigated in the serum of 
OSCC patients for early detection of cancers. Scientists are now searching for 
biomarkers in saliva, an easy to obtain body fluid, for noninvasive detection of oral 
cancer which makes the measurement of tumour markers in  saliva an attractive 
alternative to serum testing for early detection, post treatment monitoring and 
monitoring high risk lesion.
Keywords: saliva, biomarkers, oral cancer.
Introduction number of incidence of oral cancers is about 
275,000,  with  an  approximately  20-fold  Oral cancer represents only about 3 %  variation geographically. South and Southeast  in US population but in India it accounts for  Asia  (India,  Sri  Lanka,  Pakistan,  and  .[1] over 30% of all cancers . Also India accounts  Bangladesh),  France,  and  Brazil  have 
for 86% of worlds oral cancer cases(National  particularly high rates. In most countries, men 
Institute  of  Public  Health  February  2011).  have higher rates of oral cancer than women 
Thus  oral  cancer  is  a  common  human  (due to tobacco use) and higher rates of lip 
malignancy with an increasing incidence and  cancer  (due  to  sunlight  exposure  from 
with high mortality rate of ~ 50% which has  [7] outdoor occupations) not  changed  significantly  in  more  than  50 
years. Its survival rates increase significantly  Significant proportions of cancers in 
when it is detected and treated early. the initial stages are asymptomatic and are not 
diagnosed  or  treated  until  they  reach  an  An estimated 40, 250 new cases of  advanced stage. Therefore early detection is  oral cancer will be diagnosed in the United  the most effective means to reduce death from  States in 2012, and an estimated 7,850 people  this disease. Currently diagnosis depends on a  will die of the disease. This form of cancer  thorough  oral  examination  and  .[2] accounts for about 3% of cancers in men   histopathological  examination  by  taking  a  [3] and 1.5% of cancers in women . Oral cancer  biopsy. Even though a definite diagnosis is 
occurs  more  frequently  in  blacks  than  in  based on biopsy, it would be beneficial if it  .[4,5] whites .  In  India  oral  cancer  ranks  first  could  be  done  through  non  invasive 
among all cancer cases in males and is the third  techniques  like  salivary  tumour  marker 
most  common  among  females    in  many  analysis.
.[6]. regions
Saliva, a multiconstituent oral fluid, 
The  estimated  annual  worldwide  has  high  potential  for  the  surveillance  of   239
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general  health  and  disease.  Particularly,  it  salivary diagnostics. They are unusually stable  
represents a promising diagnostic fluid for the  in saliva. They include mRNA molecules that 
screening of various oral diseases. Moreover,  cells use to convey the instructions carried by 
saliva is readily available and easily collected  DNA  for  subsequent  protein  production. 
without specialized equipment or personnel.  3000  mRNAs  are  discovered  in  normal 
For  the  past  two  decades,  saliva  has  been  salivary  transcriptome.  Of  these  180  are 
increasingly evaluated as a diagnostic fluid for  common between different normal subjects 
detecting  caries  risk,  periodontitis,  oral  contributing  the  normal  salivary 
 [11] cancer,breast cancer, salivary gland diseases  transcriptome core.
and systemic disorders such as hepatitis and 
P53 is a tumour suppressor  protein  the  presence  of  human  immunodeficiency 
which is produced in cells exposed to various  virus (HIV) or hepatitis C virus. The simple 
types of DNA damaging stress. Inactivation  and non-invasive nature of saliva collection 
of this suppressor  is considered a frequent  and its high-sensitivity assay development has 
occurrence in the development   of human  led to an emphasis on the promise of salivary 
cancer. As a result, accumulation of inactive  biomarkers.  It  may  reflect  levels  of 
p53 protein is observed, which in turn may  therapeutic,  hormonal,  and  immunologic 
lead to the production of antibodies directed  molecules and can yield diagnostic markers 
against this protein. Besides its presence in  for infectious and neoplastic diseases.
sera, p53 can also be detected in the saliva of 
Discussion patients diagnosed with oral squamous cell 
carcinoma(OSCC) and can thus assist in the  There has been ever growing effort 
early  detection  of  and  screening  for  this  dedicated to the basic research of oral cancer,   [12] tumour. focusing on the identification of biological 
indicators for diagnosis of its biological nature  Salivary defensin 1 were found to be 
and  aggressiveness.  Salivary  tumour  indicative  of  the  presence  of  OSCC. 
biomarkers can be classified into proteome,  Defensins  are  proteins  which  possess 
transcriptome,micro  RNA,metabolome  and  antimicrobial and cytotoxic properties. They 
[8] microbe .Metabolome is the complete set of  are  found  in  the  azurophil  granules  of 
small-molecule metabolites such as metabolic  polymorphonuclear  leukocytes.  Higher 
intermediates, hormones and other signalling  concentration  of  salivary  defensin  1  were 
molecules, and secondary metabolites which is  detected  in  patients  with  OSCC  in 
found in a biological sample. Recent studies in  comparison with the defensin 1 concentration 
salivary protein research have shown that , in  in the saliva of patients with adenocarcinoma 
addition to major salivary  protein families ,  and  in  healthy  controls.  A  high  positive 
saliva contains hundreds of minor proteins or  correlation  was  observed  between  salivary 
peptides.  Even  though  these  proteins  are  defensin 1 levels and serum levels of OSCC 
 [13] present  in  low  concentration  salivary  related antigen .
proteomic technology play an important role 
In addition to IL 8(Interleukin 8),six  in the discrimination of disease. Proteome is 
cancer associated genes have been upregulated  the protein complement of the genome and 
in  saliva  from  oral  cancer  patients  such  as  proteomics is analysis of the portion  of the 
IL1B(Interleukin 1 ß),DUSP1(Dual Specificity  genome that is expressed. Using proteomics 
Phosphate 1),H3F3A(H3 histone, family 3A),  profiling, Hu et al identified 309 saliva proteins 
OAZ1(Ornithine decarboxylase antizyme 1),  from  a  healthy  participant  including  220 
 [9,10] S100P(S  100  calcium  binding  protein  proteins with known biological functions.
P),SAT(Spermidine/spermine  N1-
In  addition  to  salivary  proteome,  acetyltransferase) in a study by Yank li et al. 
salivary  transcriptomes  are  also  used  in  DUSP1  gene  encodes  a  dual  specificity 
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phosphatase  and  has  been  implicated  as  a  Free radicals such as reactive oxygen 
mediator  of  tumour  suppressor  PTEN  species(ROS)  and  reactive  nitrogen 
signalling  pathway.  OAZ1  is  predicted  as  a  species(RNS) are main contributers to oral 
tumour  suppressor  based  on  its  known  carcinogenesis.  In  OSCC  patients  salivary 
inhibitory function to ornithine decarboxylase.  RNS levels showed an increased level while all 
SAT and  S100P are associated with prostate  salivary  antioxidants  were  substantially 
cancer progression. The expression of IL1B is  reduced.  8-  hydroxydeoxyguanosine  (8-
also  associated  with  cancers.  Chen  et  al  OHdG) marker, a widely used indicator of 
previously demonstrated the elevation of IL 8  DNA  oxidation  is  also  seen  increased  in 
protein expression in head and neck cancer  OSCC  patients(Bahar G et al, 2006).RNS in 
tissues.   The serum level of IL1B has been  the form of nitrosamines and ROS such as 
shown to be higher in patients with OSCC.  superoxide  radicals,  hydroxyl  radicals  and 
Identification of cancer associated genes that  hydrogen  peroxide  can  cause  DNA  base 
are consistently changed in cancer patients will  alterations , strand breaks, damaged tumour 
provide us not only with diagnostic markers  suppressor genes and an enhanced expression 
but also with insights about molecular profiles  of proto oncogenes. Thus they play a key role 
[18] involved  in  head  and  neck  cancer  in human cancer development. 
 [14] development. In a study to evaluate biochemical and 
Certain bacterias were found to be in  immunological parameters   in the saliva of 
higher levels in saliva of oral cancer patients.  OSCC  patients salivary median total protein 
They are C gingivalis, P. Melaninogenica,         S  concentration    was  found  to  be  in  a 
mitis. Reason for this finding is not clear. One  significantly  higher  level    along  with  the 
explanation may relate to the altered cell surface  increased level of  Na(sodium), Ca(calcium), 
receptors observed in cancer cells. Alterations  P(inorganic phosphate) and Mg(magnesium). 
in  tumour  cell  receptors  could  change  the  Alb(Albumin),  salivary  LDH  (lactate 
 [15] dehydrogenase),  total  IgG(Immunoglobulin  adhesion of certain species of bacteria.
G) also showed increased level while Sec Ig 
Cyfra  21-1,  TPS(Tissue  Polypeptide  A(Secretory  Immunoglobulin  A)  showed  a 
Antigen) ,CEA(Circulatory Carcinoembryonic  decreased  level.  Concentrations  of  
Antigen), SCC, CA125(Carbohydrate Antigen  IGF(Insulin Growth Factor), MMP-2,MMP-
125) and CA19-9(Carbohydrate Antigen19-9)  9(metalloproteinases)  were  significantly 
are the most often studied serum circulatory  [19] higher in OSCC patients.  epithelial tumour markers. Rafael Nagler et al 
studied about the presence of these markers in  Jamee MS et al(2007) studied about the 
saliva. A significant increase was noticed for  salivary levels of proinflammatory cytokines 
Cyfra 21-1, TPS and CA19-9.Other markers  like  TNFá,  IL1á,  IL6  and  IL8  in  OSCC 
also showed an increase in concentration but  patients. They noticed a significant increase in 
were  not  significant.With  these  results  they  the  concentration  of   salivary  IL 
concluded that eventhough a definite diagnosis  6.Eventhough  others  showed  an  increase, 
of oscc  is based on biopsy , it would be highly   they were not significantly increased. In an 
desirable  and  beneficial  if  salivary  tumour  earlier study investigators found that serum 
marker analysis could be done on a routine  concentration  of  IL1á,IL6,TNFá(Tumour 
 [16] Necrosis Factor alpha),soluble TNF receptor  basis between biopsies.
I(sTNF-RI) and C reactive protein(CRP) were 
Using Proteomic profiling Hu et al have  higher  in  patients  with  OSCC  and  the 
identified 309 saliva proteins from a healthy  increased serum levels appeared to be related 
participant Their study also  revealed  the co  to the clinical stage of disease.Since various 
existence  phenomenon  between    saliva  studies showed a controversy between results  [17] proteins and mRNAs of investigations, they concluded that further   241
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studies  with  large  samples  are  needed  to  Dablesteen    et  al  have  reported  elevated 
accept or reject the utility of these cytokines in  salivary sialic acid in oral cancer. Baxi et al 
predicting  or  diagnosis  of  OSCC  or  studied the sialic acid levels in various cancers 
[20] and  reported  elevated  levels  of  sialic  acid  evaluation of treatment. 
compared to healthy subjects.PR Sanjay et al 
Substractive proteomics approach to  also observed an increased salivary  levels of 
profile salivary proteins from oral cancer and  [22] total protein and sugar in OSCC patients.  matched  healthy  subjects  followed  by 
immunoassay validation revealed a panel of  Being a filtrate of the serum, saliva has 
candidate  protein  biomarkers  for  potential  been  found  to  have  an  abundance  of 
detection of OSCC. They are M2BP(Mac 2  biomarkers  with  major  clinical 
Binding  Protein),  MRP14(Myeloid  Related  significance.The biomarker concentration in 
Protein  14),  CD59,  Catalase,  Profilin.  whole  saliva  can  be  lower  than  that  of 
Substractive  proteomics  refers  to  direct  serum.To  indicate  their  presence,  a  more 
profiling  of  proteins  expressed  in  samples  sensitive    protein  sensor  is  needed.  So   
from two cellular or pathologic states using  confocal optical protein sensors can be used 
multidimensional  LC  separation  and  data  to  detect  biological  markers  with  lower 
[23] dependent  MS/MS  analysis.  In  a  previous  concentration 
study  M2BP  ,  tumour  antigen  was  found 
Five  markers  were  found  to  be  significantly  upregulated  in  nasopharyngeal 
increased in saliva of cancer patients in a study  carcinoma. An increased level of MRP14 has 
by Shptizer et al. They are carbonyls, lactate  been previously reported in tissue cells of oral 
d e h y d r o g e n a s e ( L D H ) , M M P   tongue cancer.CD59(protectin) is one of the 
9(Metalloproteinase 9), Ki67(Antigen Ki 67),  compliment  restriction  factors  that  are 
and CycD1(Cyclin D).An increase in salivary  overexpressed  on  tumour  cells  ,  and  they 
carbonyls is pointing at the significant free  enable  tumour  cells  to  escape  from 
radicals attack to   which the epithelial cells  compliment-dependent  and  antibody 
have been exposed.CycD1 and Ki67 are cell  mediated killing. Profilin 1 is a regulator of the 
cycle regulators, which have been shown to be  microfilament  system  and  is  involved  in 
correlated  with  cellular  proliferation  and  various  signalling  pathways  via  interactions 
tumour  progression,  metastasis  and  poor  with cytoplasmic and nuclear ligands..Catalase 
prognosis. LDH was found to increase in the  protects the cell against oxidative stress and 
serum of various malignancies  and has been  altered levels of catalase are evident in many 
identified  as  the  main  recurrent  adverse  human  tumours  and  are  fundamentally 
prognostic factors. MMP was earlier shown to  involved  in  carcinogenesis  and  tumour 
be  elevated  in  saliva.  MMP  9  are  [21] progression.    metalloproteases  that  have  been  shown  to 
Sanjay  PR  etal  (2008)  conducted  a  participate  in  cancer  pathogenesis  as  they 
study  to  evaluate  the  role  of  salivary  degrade type IV  collagen, a major component 
biochemical  parameters  as  markers  of  of basement membrane as well as other types 
OSCC.They have found a significantly higher  of collagens, elastin and fibronectin.They are 
amount of free sialic acid in well differentiated  highly expressed in stromal cells surrounding 
OSCC  patients  compared  with  those  of  the invading front of metastasing tumors  and 
moderately differentiated OSCC suggesting  a  their  levels  are  elevated  in  tumour 
[24] correlation  of  elevated  salivary  sialic  acid  endothelium and in urine of cancer patients. 
levels to the progression of OSCC. Sialic acid 
There  were  previous  reports  that  is  a  constituent  of   many  salivary 
salivary mRNAs can be used as biomarkers for  glycoproteins. Studies have reported elevated 
oral cancer. To enhance the diagnostic power  salivary  levels  of  sialic  acid  in  pregnancy, 
of saliva for oral cancer, Park NJ etal  profiles  Down's  syndrome  and  Diabetes  mellitus.   242
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salivary mi RNAs(micro RNAs) to determine  combination  yielded  satisfactory  accuracy, 
if any miRNAs could be used as potential  sensitivity, specificity and positive predictive 
diagnostic  markers.  Study  showed  that  value in distinguishing OSCC from controls. 
endogenous plasma miRNAs are more stable  The utility of salivary metabolome diagnostics 
than  exogenous  miRNAs.  They  detected  for oral cancer is successfully demonstrated in 
about  50  miRNAs  in  both  whole  and  this  study  and  these  results  suggest  that 
supernatant saliva. Of these they noticed that  metabolomics  approach  compliments  the 
two salivary miRNAs ,  miR -200a and miR- clinical detection of OSCC , leading to an 
 .[27] 125a  were  present  at  lower  levels  in  oral  improved disease diagnosis and prognosis.
squamous cell carcinoma patient saliva than in  Cd44 proteins, one of the adhesion 
healthy  controls.  Through  transient  molecules  are  released  in  soluble  form 
transfection studies , miR-125a along with it  (sCD44) via proteases and are detectable in 
homologue miR-125b , have been shown to  normal circulation.The interaction of CD44 
reduce  ERBB2  and  ERBB3  oncogenic  with  many  receptor-mediated  signalling 
protein levels in SKBR3 cell, a human breast  pathways has been shown to promote various 
cancer cell line.miR200a has been reported to  tumor progression behaviors, including tumor 
be differentially expressed in head and neck  cell  growth,  migration,  invasion,  and  [25] cancer cell lines and other cancer cells.  metastasis.In the study by Ghalwash DM et al 
Via  bioinformatic  analysis  and  ,levels  of  soluble  CD44  (sCD44)  were 
biochemical  validations,  de  Jong  EP  etal  measured in whole unstimulated saliva (WUS) 
(2010)   have identified myosin and actin as  using  an  enzyme  linked  immune-  assay 
promising  salivary  biomarkers  capable  of  (ELISA)and a significant increase in salivary 
distinguishing  between  subjects  with  sCD44 level was found in oral cancer patients 
premalignant and malignant lesions.Actin and  making it a potential molecular marker for oral 
[28] myosin are key cytoskeletal proteins enabling  cancer detection .
cell motility and invasion,behaviour central to  Conclusion 
epithelial  tumorigenesis.  Both  proteins 
The  significant  increase  in  salivary  displayed increases in their abundance levels in 
tumour markers is encouraging in light of the  soluble saliva from subjects with malignant 
many  advantages  of  saliva  analysis  in  lesions.  Additionally  both  proteins  showed 
comparison  with  serum  analysis.  Biopsy  abundance  increases  in  the  exfoliated  cells 
remains  the  gold  standard  for  definitive  from  the  saliva  of  same  subjects.  These 
diagnosis of oral squamous cell carcinoma but  findings provided  critical  evidence  that the 
it would be highly desirable and beneficial if  differences observed in the soluble fraction of 
salivary tumour markers may be made as a  saliva are most likely a direct result of protein 
diagnostic tool, especially when a concurrant  differences  occurring  within  the  epithelial 
analysis for significantly increased markers is  cells  during  the  transition  from  a  pre-
.[26] done. That is because salivary harvesting is  malignancy to malignancy 
noninvasive which may make it an attractive, 
A panel of five salivary metabolites  effective alternative to serum testing. However 
including Y- aminobutyric acid, phenylalanine,  , caution should be taken and note made of the 
valine, n-eicosanoic acid and lactic acid were  fact that this suggested salivary analysis may be 
selected for study by Wie J et al (2011).The  regarded as an aid and not as a replacement for 
predictive power of each of the five salivary  other  well  established  diagnostic  tools 
metabolites  was  evaluated  by  receiver  available  for  oral  squamous  cell 
operating  characteristic  curves  for  OSCC.  carcinoma.
Valine,  lactic  acid  and  phenylalanine  in   243
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